Etlinger and Goldberg28 were the first to isolate and characterize a cell-free proteolytic preparation from reticulocytes. The crude extract selectively degraded abnormal hemoglobin, required ATP hydrolysis, and acted optimally at a neutral pH, which further corroborated the assumption that the proteolytic activity was of a non-lysosomal origin. A similar system was isolated and characterized later by Hershko et al.29 Additional studies by this group led subsequently to resolution, characterization, and purification of the major enzymatic components from this extract and to the discovery of
the Inhibitors,research,lifescience,medical ubiquitin signaling system (see below). THE LYSOSOME HYPOTHESIS IS CHALLENGED As mentioned above, the unraveled mechanism(s) of action of the lysosome could explain only partially, and at times not satisfactorily, several key emerging characteristics of intracellular protein degradation. Among them were the heterogeneous stability of individual proteins, the effect of nutrients and hormones on their degradation, and the dependence of intracellular proteolysis Inhibitors,research,lifescience,medical on metabolic energy. Inhibitors,research,lifescience,medical The differential effect of selective inhibitors on the degradation of different classes of cellular proteins (see above but mostly below) could not be explained at all. The evolution of click here methods to monitor protein kinetics in cells, together with the development of specific and general lysosomal inhibitors, has resulted in the identification of different
classes of cellular proteins, long- and short-lived, and the discovery of the differential effects of the inhibitors on these groups (see, for example, Knowles et al.30 and Neff et al.31). An elegant experiment in this Inhibitors,research,lifescience,medical respect was carried out by Brian Poole and his colleagues in the Rockefeller University. Poole was studying the effect of lysosomotropic Inhibitors,research,lifescience,medical agents, weak bases such as ammonium chloride and chloroquine, which accumulate in the lysosome and dissipate its low acidic pH. It was assumed that this mechanism underlies also the anti-malarial activity of chloroquine and similar
drugs where they inhibit the activity of the parasite’s lysosome, “paralyzing” its ability to digest the host’s hemoglobin during the intra-erythrocytic stage of its life cycle. Poole and his colleagues metabolically labeled endogenous proteins in living macrophages PDK4 with 3H-leucine and “fed” them with dead macrophages that had been previously labeled with 14C-leucine. They assumed, apparently correctly, that the dead macrophage debris and proteins will be phagocytosed by live macrophages and targeted to the lysosome for degradation. They monitored the effect of lysosomotropic agents on the degradation of these two protein populations; in particular, they studied the effect of the weak bases chloroquine and ammonium chloride (which enter the lysosome and neutralize the H+ ions) and the acid ionophore X537A which dissipates the H+ gradient across the lysosomal membrane.